Conggang Zhang1, Schuyler Lee1, Yinghua Peng1, Eric Bunker1, Emilie Giaime2, Jie Shen2, Zongyao Zhou1, Xuedong Liu3. 1. Department of Chemistry and Biochemistry, 3415 Colorado Avenue, Jennie Smoly Caruthers Biotechnology Building, University of Colorado Boulder, Boulder, CO 80303, USA. 2. Center for Neurologic Diseases, Brigham and Women's Hospital, Program in Neuroscience, Harvard Medical School, New Research Building, Room 636E, 77 Avenue Louis Pasteur, Boston, MA 02115, USA. 3. Department of Chemistry and Biochemistry, 3415 Colorado Avenue, Jennie Smoly Caruthers Biotechnology Building, University of Colorado Boulder, Boulder, CO 80303, USA. Electronic address: xuedong.liu@colorado.edu.
Abstract
BACKGROUND: The PINK1-Parkin pathway is known to play important roles in regulating mitochondria dynamics, motility, and quality control. Activation of this pathway can be triggered by a variety of cellular stress signals that cause mitochondrial damage. How this pathway senses different levels of mitochondrial damage and mediates cell fate decisions accordingly is incompletely understood. RESULTS: Here, we present evidence that PINK1-Parkin has both cytoprotective and proapoptotic functions. PINK1-Parkin operates as a molecular switch to dictate cell fate decisions in response to different cellular stressors. Cells exposed to severe and irreparable mitochondrial damage agents such as valinomycin can undergo PINK1-Parkin-dependent apoptosis. The proapoptotic response elicited by valinomycin is associated with the degradation of Mcl-1. PINK1 directly phosphorylates Parkin at Ser65 of its Ubl domain and triggers activation of its E3 ligase activity through an autocatalytic mechanism that amplifies its E3 ligase activity toward Mcl-1. CONCLUSIONS: Autocatalytic activation of Parkin bolsters its accumulation on mitochondria and apoptotic response to valinomycin. Our results suggest that PINK1-Parkin constitutes a damage-gated molecular switch that governs cellular-context-specific cell fate decisions in response to variable stress stimuli.
BACKGROUND: The PINK1-Parkin pathway is known to play important roles in regulating mitochondria dynamics, motility, and quality control. Activation of this pathway can be triggered by a variety of cellular stress signals that cause mitochondrial damage. How this pathway senses different levels of mitochondrial damage and mediates cell fate decisions accordingly is incompletely understood. RESULTS: Here, we present evidence that PINK1-Parkin has both cytoprotective and proapoptotic functions. PINK1-Parkin operates as a molecular switch to dictate cell fate decisions in response to different cellular stressors. Cells exposed to severe and irreparable mitochondrial damage agents such as valinomycin can undergo PINK1-Parkin-dependent apoptosis. The proapoptotic response elicited by valinomycin is associated with the degradation of Mcl-1. PINK1 directly phosphorylates Parkin at Ser65 of its Ubl domain and triggers activation of its E3 ligase activity through an autocatalytic mechanism that amplifies its E3 ligase activity toward Mcl-1. CONCLUSIONS: Autocatalytic activation of Parkin bolsters its accumulation on mitochondria and apoptotic response to valinomycin. Our results suggest that PINK1-Parkin constitutes a damage-gated molecular switch that governs cellular-context-specific cell fate decisions in response to variable stress stimuli.
Authors: Nicholas T Hertz; Amandine Berthet; Martin L Sos; Kurt S Thorn; Al L Burlingame; Ken Nakamura; Kevan M Shokat Journal: Cell Date: 2013-08-15 Impact factor: 41.582
Authors: Sven Geisler; Kira M Holmström; Angela Treis; Diana Skujat; Stephanie S Weber; Fabienne C Fiesel; Philipp J Kahle; Wolfdieter Springer Journal: Autophagy Date: 2010-10-03 Impact factor: 16.016
Authors: Anne Kathrin Müller-Rischart; Anna Pilsl; Patrick Beaudette; Maria Patra; Kamyar Hadian; Maria Funke; Regina Peis; Alexandra Deinlein; Carolin Schweimer; Peer-Hendrik Kuhn; Stefan F Lichtenthaler; Elisa Motori; Silvana Hrelia; Wolfgang Wurst; Dietrich Trümbach; Thomas Langer; Daniel Krappmann; Gunnar Dittmar; Jörg Tatzelt; Konstanze F Winklhofer Journal: Mol Cell Date: 2013-02-28 Impact factor: 17.970
Authors: M Klinkenberg; N Thurow; S Gispert; F Ricciardi; F Eich; J H M Prehn; G Auburger; D Kögel Journal: Neuroscience Date: 2010-01-04 Impact factor: 3.590
Authors: Fabienne C Fiesel; Thomas R Caulfield; Elisabeth L Moussaud-Lamodière; Kotaro Ogaki; Daniel F A R Dourado; Samuel C Flores; Owen A Ross; Wolfdieter Springer Journal: Hum Mutat Date: 2015-06-03 Impact factor: 4.878
Authors: Jonathan P Bernardini; Jason M Brouwer; Iris Kl Tan; Jarrod J Sandow; Shuai Huang; Che A Stafford; Aleksandra Bankovacki; Christopher D Riffkin; Ahmad Z Wardak; Peter E Czabotar; Michael Lazarou; Grant Dewson Journal: EMBO J Date: 2018-12-20 Impact factor: 11.598